As 2025 unfolded, returning to the ritual of asking filmmakers about the films that moved them feels both fragile and ...
Company remains focused on potential approval and launch of IGALMI® for the acute treatment of agitation associated with bipolar disorders or schizophrenia in the at-home setting NEW HAVEN, Conn., Jan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback